Organigram Global (0OG) Price & Analysis

Q: What was Organigram Global’s price range in the past 12 months?

Organigram Global lowest stock price was €0.74 and its highest was €1.82 in the past 12 months.

Q: What is Organigram Global’s market cap?

Organigram Global’s market cap is €121.42M.

Q: When is Organigram Global’s upcoming earnings report date?

Organigram Global’s upcoming earnings report date is Dec 22, 2026 which is in 131 days.

Q: How were Organigram Global’s earnings last quarter?

Organigram Global released its earnings results on Aug 11, 2026. The company reported €0.473 earnings per share for the quarter, beating the consensus estimate of -€0.006 by €0.479.

Q: Is Organigram Global overvalued?

According to Wall Street analysts Organigram Global’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Organigram Global pay dividends?

Organigram Global does not currently pay dividends.

Q: What is Organigram Global’s EPS estimate?

Organigram Global’s EPS estimate is 0.01.

Q: How many shares outstanding does Organigram Global have?

Organigram Global has 136,468,690 shares outstanding.

Q: What happened to Organigram Global’s price movement after its last earnings report?

Organigram Global reported an EPS of €0.473 in its last earnings report, beating expectations of -€0.006. Following the earnings report the stock price went up 4.798%.

Q: Which hedge fund is a major shareholder of Organigram Global?

Currently, no hedge funds are holding shares in DE:0OG

2 Followers

0OG Stock Chart & Stats

€0.80

<€0.01(0.63%)

At close: Jul 28 4:00 PM EDT

€0.80

<€0.01(0.63%)

Day’s Range― - ―

52-Week Range€0.74 - €1.82

Previous CloseN/A

Volume0.00

Average Volume (3M)224.00

Market Cap

€121.42M

Enterprise Value€217.07

Total Cash (Recent Filing)€54.75M

Total Debt (Recent Filing)€8.20M

Price to Earnings (P/E)―

Beta0.94

Next Earnings

Dec 22, 2026

EPS Estimate

0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.18

Shares Outstanding136,468,690

10 Day Avg. Volume521

30 Day Avg. Volume224

Financial Highlights & Ratios

PEG Ratio0.25

Price to Book (P/B)1.03

Price to Sales (P/S)1.39

P/FCF Ratio-14.61

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€1.94

Price Target Upside143.05% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)0.07

Revenue Forecast (FY)€209.35M

Bulls Say, Bears Say

Bulls Say

Acquisition And European ExpansionAnalyst considers the acquisition strategically significant as it positions Organigram in Germany and creates a platform to expand across European markets, supporting potential revenue growth.

Higher-margin Product SalesAnalyst notes the deal enables Organigram to sell higher-margin flower into European markets, which could improve overall profitability as international sales scale.

Operational Strength And DistributionAnalyst points to Sanity Group's improving gross margins and positive operating profitability, together with the Motif acquisition's added sales channels, as elements that can strengthen margins and accelerate top-line growth.

Bears Say

Balance Sheet Impact And Shareholder DilutionAnalyst warns the transaction requires cash and issuance of Organigram shares, which could weaken the balance sheet and alter shareholder structure through dilution.

Operational Disruption And Product Quality RiskAnalyst highlights operational disruptions and product quality issues that constrained international shipments and increased competitive pressure in certain categories, posing execution risk.

Revenue And Earnings ShortfallAnalyst reports net revenue missed expectations because international sales were weaker and domestic adult-use demand softened, resulting in adjusted operating earnings falling short of forecasts.

Organigram Global News

Options Volatility and Implied Earnings Moves Today, August 11, 2026

Today, several major companies are expected to report earnings: Cardinal Health (CAH), Super Micro Computer (SMCI), Lumentum Holdings...

2d ago

CAH

Organigram reports Q3 net revenue $105.78M vs. $70.79M last year

Reports Q3 adjusted EBITDA $13.4M vs. $5.69M last year. “This quarter marks an important milestone for Organigram (OGI)...

2d ago

OGI

Organigram Earns Buy Rating as Sanity Acquisition Drives Record EBITDA and Reaffirms Strong FY Outlook

In a report released yesterday, Neal Gilmer from Haywood maintained a Buy rating on Organigram Global, with a...

21h ago

OGI

Organigram Posts Record Q3 2026 Results on Sanity Group-Driven Global Expansion

Organigram Global ( ($TSE:OGI) ) has issued an update. Organigram reported record third-quarter fiscal 2026 results, driven largely...

2d ago

OGI

Is OGI a Buy, Before Earnings?

Organigram Global Inc. (OGI) is scheduled to report 3rd quarter earnings on 08/11/2026, before the market opens. Regarding...

4d ago

OGI

Organigram Global Sets August 11 Date for Q3 2026 Results

An announcement from Organigram Global ( ($TSE:OGI) ) is now available. Organigram Global Inc., Canada’s largest cannabis company...

8d ago

OGI

Organigram Highlights Strong Canadian Cannabis Position and Solid Early Performance from Sanity Acquisition

An announcement from Organigram Global ( ($TSE:OGI) ) is now available. Organigram Global, Canada’s leading cannabis company by...

23d ago

OGI

OGI Earnings Report this Week: Is It a Buy, Ahead of Earnings?

OrganiGram Holdings (OGI) is scheduled to report 3rd quarter earnings on 07/09/2026. Regarding Q3 estimates, Wall Street analysts...

1M ago

OGI

Organigram Global Files Q2 2026 Results as Sanity Group Deal Extends European Cannabis Reach

Organigram Global ( ($TSE:OGI) ) just unveiled an announcement. Organigram Global Inc., a Canadian cannabis cultivator and producer...

3M ago

OGI

Options Volatility and Implied Earnings Moves Today, May 12, 2026

Today, several major companies are expected to report earnings: Lineage Therap (LCTX), Achieve Life Sciences (ACHV), Zebra Tech...

3M ago

LAR

OGI

Organigram reports Q2 net revenue $59.8M, consensus $68.83M

Reports Q2 adjusted EBITDA $870K vs. $4.91 M last year. Reports Q2 gross revenue $93.3M. “Q2 reflected our...

3M ago

OGI

Organigram sees FY26 revenue over $350M, consensus $341.45M

Sees FY26 adjusted EBITDA higher than FY25 and CapEx of less than $10M. Published first on TheFly –...

3M ago

OGI

Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026

This week, several major companies will be reporting earnings. Among them are Alibaba (BABA), Plug Power (PLUG), D-Wave...

3M ago

Organigram closes acquisition of Sanity Group

Organigram (OGI) Global and Sanity Group jointly announced the successful closing of Organigram’s previously announced acquisition of Sanity...

4M ago

OGI

0OG FAQ

What was Organigram Global’s price range in the past 12 months?

Organigram Global lowest stock price was €0.74 and its highest was €1.82 in the past 12 months.

What is Organigram Global’s market cap?

Organigram Global’s market cap is €121.42M.

When is Organigram Global’s upcoming earnings report date?

Organigram Global’s upcoming earnings report date is Dec 22, 2026 which is in 131 days.

How were Organigram Global’s earnings last quarter?

Organigram Global released its earnings results on Aug 11, 2026. The company reported €0.473 earnings per share for the quarter, beating the consensus estimate of -€0.006 by €0.479.

Is Organigram Global overvalued?

According to Wall Street analysts Organigram Global’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Organigram Global pay dividends?

Organigram Global does not currently pay dividends.

What is Organigram Global’s EPS estimate?

Organigram Global’s EPS estimate is 0.01.

How many shares outstanding does Organigram Global have?

Organigram Global has 136,468,690 shares outstanding.

What happened to Organigram Global’s price movement after its last earnings report?

Organigram Global reported an EPS of €0.473 in its last earnings report, beating expectations of -€0.006. Following the earnings report the stock price went up 4.798%.

Which hedge fund is a major shareholder of Organigram Global?

Currently, no hedge funds are holding shares in DE:0OG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Organigram Global Stock Smart Score

Outperform

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

39.72%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Organigram Global

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

Organigram Global (0OG) Earnings & Revenues

Historic Earnings Reports

0OG Earnings Call

Q3 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call communicated strong operational and financial momentum driven largely by the Sanity acquisition: record revenue, margin expansion, record adjusted EBITDA, and meaningful international diversification. Operational improvements in cultivation and category share gains in Canada reinforce the positive narrative. Key risks include negative free cash flow driven by working capital build, pending EU-GMP certification and tight EU-GMP supply into Germany, earlier vape/pre-roll quality issues in Canada, and U.S. regulatory uncertainty. Net income was materially boosted by non-cash fair value gains, so underlying cash generation and integration-related working capital remain focal concerns. On balance, the positive financial results, strategic diversification, and improving margin trajectory outweigh the liquidity and regulatory challenges discussed.View all DE:0OG earnings summaries

0OG Stock 12 Month Forecast

Average Price Target

€1.94

▲(143.05% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","1":"€1","2":"€2","3":"€3","-1":"-€1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.02215663,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.944381375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.8666061200000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.87</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.815,0.9078582023076922,1.0007164046153845,1.093574606923077,1.1864328092307692,1.2792910115384615,1.372149213846154,1.4650074161538462,1.5578656184615385,1.6507238207692307,1.743582023076923,1.8364402253846155,1.9292984276923077,{"y":2.02215663,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.815,0.9018754903846153,0.9887509807692307,1.0756264711538461,1.1625019615384615,1.249377451923077,1.3362529423076923,1.4231284326923077,1.510003923076923,1.5968794134615385,1.683754903846154,1.7706303942307693,1.8575058846153847,{"y":1.944381375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.815,0.8958927784615385,0.9767855569230769,1.0576783353846153,1.1385711138461538,1.2194638923076924,1.3003566707692307,1.3812494492307692,1.4621422276923077,1.5430350061538463,1.6239277846153848,1.704820563076923,1.7857133415384616,{"y":1.8666061200000001,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.15,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.44,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.33,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.4,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.14,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.17,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.14,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.948,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.867,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.815,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >